Solvay S187.3.005: Open-Label, Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease and Severe Motor Fluctuations who have Exhibited A Persistent and Positive Effect to Treatment

Grants and Contracts Details

StatusFinished
Effective start/end date6/8/10 → 12/31/16

Funding

  • Quintiles Inc: $492,944.00